Infectious Disease Diagnostics Market Size | Global Report 2028

The infectious disease diagnostics market is expected to grow from US$ 23,890 million in 2021 to US$ 37,943.90 million by 2028; it is estimated to grow at a CAGR of 6.8% from 2021 to 2028

Infectious diseases are generated by microorganisms such as fungi, viruses, bacteria, and other organisms. Infectious disease diagnostics are the methods hospitals and clinical laboratories use to detect or identify foreign antigens/organisms by using several diagnostic tests. These tests assist in identifying the type of pathogen and the extent of the degree to which the disease is spread in the body. The diagnostic procedure is performed with the aid of conventional diagnostic tests or point-of-care testing tools.

The infectious disease diagnostics market is segmented on the basis of product, disease indication, technology, testing type, end user, and geography. By geography, the infectious disease diagnostics market is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The infectious disease diagnostics market report offers insights and in-depth analysis of the market, emphasizing parameters such as market size, trends, technological advancements, and market dynamics, and the analysis of the competitive landscape of the globally leading market players.

The growth of the infectious disease diagnostics market is attributed to growing awareness for early disease diagnosis, a shift in focus from centralized laboratories to decentralized POC testing, and rising technological advancements. However, the high cost associated with diagnostic instruments restricts the market growth.

Strategic Insights

Lucrative Regions in Infectious Disease Diagnostics Market

Get more information on this report : Request Free Sample PDF

Market Insights

Rising Prevalence of Infectious Diseases

Infectious diseases are caused by infectious agents, such as viruses, bacteria, parasites, fungi, and toxic products. HIV is a major public health issue across the world. According to The Joint United Nations Programme on HIV/AIDS (UNAIDS), ~ 37.7 million people had HIV in 2020. Out of these, 1.7 million were children aged 0–14 years, and 36 million were adults. Also, more than half (53%) were girls and women. 1.5 million new HIV cases were reported in 2020 globally. Similarly, hepatitis is inflammation of the liver caused by a viral infection. The five main strains of hepatitis viruses are A, B, C, D, and E. According to World Health Organization (WHO), around 58 million people across the globe have chronic hepatitis C virus infection, and ~1.5 million new infections occur every year.

According to World Health Organization (WHO) tuberculosis (TB) is the 13th top cause of death globally and the second leading infectious disease after COVID-19. According to the WHO, there were 1.5 million deaths caused by TB in 2020 (including 214,000 people affected by HIV). In 2020, WHO projected that 10 million people had TB globally, including 1.1 million children, 3.3 million women, and 5.6 million men. TB is present in all age groups and countries. Furthermore, in 2020, 30 countries with high TB burdens accounted for 86% of new TB cases. Eight countries make up two-thirds of the total, with India at the forefront, followed by China, the Philippines, Indonesia, Nigeria, Pakistan, Bangladesh, and South Africa.  Diagnostics play an essential role in determining the direction of any medical treatment of infectious diseases. Therefore, the rising prevalence of infectious diseases across the globe propels the growth of the infectious disease diagnostics market. 

Product-Based Insights

Based on product, the global infectious disease diagnostics market , based on product, has beenis segmented into kits and reagents, instruments, and software and services  . In 2021, the kits and reagents held the largest share of the market, by product. However, the software and services segment are is expected to witness growth in its demand at a fastestregister the highest CAGR during from 2021 to 2028.

Infectious Disease Diagnostics Market, by Product – 2021 and 2028

Get more information on this report : Request Free Sample PDF

Disease Indication-Based Insights

Based on disease indication, the global infectious disease diagnostics market , based on disease indication, is segmented into HIV, hepatitis, healthcare- associated infections (HAIs), human papillomavirus (HPV), tuberculosis (TB), influenza, and others disease indications. The hepatitis segment held the largest share of the market in 2021. However, the healthcare- associated infections (HAIs) segment is anticipated to register the highest CAGR during the forecast period.  

Technology-Based Insights

Based on technology, the global infectious disease diagnostics market , based on technology, has beenis segmented into immunodiagnostics, polymerase chain reaction, next generation sequencing, clinical microbiology, and others. In 2021, the immunodiagnostics segment held the largest share of the market, by technology. However, the next generation sequencing segment is expected to witness growth in its demand at a fastestregister the highest CAGR during from 2021 to 2028.

Testing Type-Based Insights

Based on testing type, the global infectious disease diagnostics market, based on testing type, has been is segmented bifurcated into laboratory testing and point of- care testing immunodiagnostics, polymerase chain reaction, next generation sequencing, clinical microbiology, and others. In 2021, the immunodiagnostics laboratory testing segment held the largest share of the market, by testing type. However, the next generation sequencingpoint -of -care testing segment is expected to witness growth in its demand at a fastest CAGR during 2021 to 2028.

End User-Based Insights

Based on end user, the global infectious disease diagnostics market is, based on end user, has been segmented into hospitals & clinics, pathology or diagnostic laboratories, research institutes, home care settings, and others.  In 2021, the pathology or diagnostic laboratories segment held the largest share of the market, by end user. However, the home care settings segment is expected to witness growth in its demand at a fastestregister the highest CAGR during from 2021 to 2028.

Several companies adopt strategies, such as product launches and approvals, to expand their global footprints and product portfolios. Moreover, the infectious disease diagnostics market players focus on the partnership strategy to enlarge their clientele, which permits them to maintain their brand name globally. The market share is anticipated to flourish with the development of new innovative products by market players. Danaher; Abbott; BD; Trinity Biotech; F. HOFFMANN-LA ROCHE LTD.; Cardinal Health Inc.; bioMerieux SA; BIO-RAD LABORATORIES INC.; AccuBioTech Co., Ltd.; and ACON Laboratories, Inc. are among the leading companies operating in the global infectious disease diagnostics market.